Aptevo Therapeutics Inc. Gains 81.91%
Wed, Jun 18, 2025 at 07:13 PM
Aptevo Therapeutics Inc. (APVO:NASDAQ) soared at $5.13, representing a gain of 81.9%. On Wed, Jun 18, 2025, APVO:NASDAQ hit a New 2-Week High of $5.13. The stock appeared on our News Catalysts scanner on Wed, Jun 18, 2025 at 10:24 AM in the 'BIOTECH' category. From Wed, Jun 04, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jun 18, 2025 at $13.11 with a volume of 123M+.
About Aptevo Therapeutics Inc. (APVO:NASDAQ)
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 9900.02%
- Ryde Group Ltd. (RYDE:NYSEMKT), 155.1%
- Nature Wood Group Limited (NWGL:NASDAQ), 142.67%
- KWESST Micro Systems Inc. (KWE:NASDAQ), 94.96%
- PTL Limited (PTLE:NASDAQ), 84.44%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 81.91%
- Marin Software Incorporated (MRIN:NASDAQ), 69.41%
- LZ Technology Holdings Limited (LZMH:NASDAQ), 53.8%
- Amaze Holdings, Inc. (AMZE:NYSEMKT), 53.7%
- Immuneering Corporation (IMRX:NASDAQ), 52.2%